Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Brain Injuries D001930 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki N et al. Mechanosensitive properties of gastric vagal afferent fibers in the rat. 1999 J. Neurophysiol. pmid:10561400
Torras J et al. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. 1999 Kidney Int. pmid:10571788
Bratt T et al. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands. 1999 Biochim. Biophys. Acta pmid:10572948
Grutters JC et al. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. 1999 Eur. Respir. J. pmid:10573242
Tekgül H et al. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. 1999 J. Child Neurol. pmid:10573462
Olszanecki R and Chłopicki S Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia. 1999 J. Physiol. Pharmacol. pmid:10574473
Kuśnierz B and Naskalski JW [Mediators of the inflammatory response in the course of acute pancreatitis]. 1999 Prz. Lek. pmid:10575924
Grassi S et al. Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 1999 Neuroscience pmid:10579215
Quinn JV and Slotman GJ Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. 1999 Crit. Care Med. pmid:10579269
Goldfarb R Investigations into the polydeterminant nature of sepsis. 1999 Crit. Care Med. pmid:10579296
Mizuki M et al. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor. 1999 Life Sci. pmid:10579457
Shin BA et al. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis. 1999 J. Nat. Prod. pmid:10579872
Rodrigues CO et al. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi. 1999 Biochem. Biophys. Res. Commun. pmid:10581161
Wu R et al. Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome. 1999 J. Intern. Med. pmid:10583710
Hendrickson HS et al. Intramolecularly quenched BODIPY-labeled phospholipid analogs in phospholipase A(2) and platelet-activating factor acetylhydrolase assays and in vivo fluorescence imaging. 1999 Anal. Biochem. pmid:10585741
Byrum RS et al. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. 1999 J. Immunol. pmid:10586081
Kafoury RM et al. Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. 1999 Am. J. Respir. Crit. Care Med. pmid:10588609
Kitsiouli EI et al. Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates. 1999 J. Lipid Res. pmid:10588961
Burns AR et al. Analysis of tight junctions during neutrophil transendothelial migration. 2000 J. Cell. Sci. pmid:10591624
Arbabi S et al. Priming interleukin 8 production: role of platelet-activating factor and p38. 1999 Arch Surg pmid:10593333